A gynecological preparation from Richter has received marketing authorization in Japan
The partner of Richter Gedeon Nyrt., Fuji Pharma Co., Ltd., received the marketing authorization for the Alyssa combination tablet developed in Japan. The approval means a milestone payment of 10 million euros for Richter’s 100 percent subsidiary, Estetra SRL, Richter announced on Tuesday on the website of the Budapest Stock Exchange.
The Alyssa combined tablet is a preparation for the treatment of dysmenorrhea – painful, crampy menstruation – which contains, among other things, a natural estrogen (estetrol), which has marketing rights in Japan and Southeast Asia.
In the Association of Nations (ASEAN) region, Fuji acquired it from Estetra SRL.
Fuji Alyssa is preparing to launch the combination pill under the trade name to provide a new treatment option for dysmenorrhoea patients.
Related news
According to a survey, young people value sustainability and environmental expectations the most
Young people primarily expect sustainability and the protection of environmental…
Read more >Related news
Interesting facts about World Coffee Day that you didn’t know about McCafé
McCafé has established itself among Hungarian coffee shops in the…
Read more >
Hungary may be at a competitive disadvantage in the fight for guest workers
Over the past three years, more than 100,000 guest workers…
Read more >
Waitrose Launches ‘BrandsNew’ Innovation Programme
Waitrose has announced the launch of ‘BrandsNew’, a new branded…
Read more >
